Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
07 Septembre 2022 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Morgan Stanley Global Healthcare Conference in New
York, NY.
Management is scheduled to participate on Tuesday, September 13,
2022, at 7:20 am ET and will hold one-on-one meetings following.
Interested parties may access a live and recorded webcast of the
presentation on the “Investor Relations” section of the company’s
website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220907006085/en/
Senseonics Investor Relations: Philip Taylor Investor
Relations 415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Nov 2023 à Déc 2023
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Déc 2022 à Déc 2023